Primary CNS Lymphoma

​Trials listed below that do not have a blue link are not currently open to accrual


Protocol #

​Sponsor

​Title

​OSU 10047 ​Oregon H&S Univ ​A Phase I/II Study of Patients with Newly Diagnosed Primary Central Nervous System Lymphoma Treated with Methotrexate/BBBD, and Adding Rituximab (an anti CD-20 Antibody) and Carboplatin, to the Treatment Regimen



For more information, contact:

Jill Brown
Jill.Brown@osumc.edu
614-293-5554

   

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu